Search
Now showing items 1-1 of 1
Lenalidomide maintenance after first-line therapy for high-risk chronic lymphocytic leukaemia (CLLM1): final results from a randomised, double-blind, phase 3 study
Fink, Anna Maria et al. (2017)
Wissenschaftlicher Artikel